Vistagen Therapeutics Stock Market Value
| VTGN Stock | USD 4.72 0.11 2.28% |
| Symbol | VistaGen |
VistaGen Therapeutics Price To Book Ratio
Is VistaGen Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VistaGen Therapeutics. If investors know VistaGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VistaGen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Revenue Per Share 0.077 | Quarterly Revenue Growth 1.291 | Return On Assets (0.26) | Return On Equity (0.45) |
The market value of VistaGen Therapeutics is measured differently than its book value, which is the value of VistaGen that is recorded on the company's balance sheet. Investors also form their own opinion of VistaGen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VistaGen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VistaGen Therapeutics' market value can be influenced by many factors that don't directly affect VistaGen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VistaGen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VistaGen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VistaGen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VistaGen Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VistaGen Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VistaGen Therapeutics.
| 03/25/2024 |
| 04/24/2024 |
If you would invest 0.00 in VistaGen Therapeutics on March 25, 2024 and sell it all today you would earn a total of 0.00 from holding VistaGen Therapeutics or generate 0.0% return on investment in VistaGen Therapeutics over 30 days. VistaGen Therapeutics is related to or competes with Synlogic, Effector Therapeutics, Galera Therapeutics, AC Immune, TRACON Pharmaceuticals, Entera Bio, and Tempest Therapeutics. VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing vario... More
VistaGen Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VistaGen Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VistaGen Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.84 | |||
| Information Ratio | 0.0134 | |||
| Maximum Drawdown | 23.45 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 8.23 |
VistaGen Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VistaGen Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VistaGen Therapeutics' standard deviation. In reality, there are many statistical measures that can use VistaGen Therapeutics historical prices to predict the future VistaGen Therapeutics' volatility.| Risk Adjusted Performance | 0.0311 | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0146 | |||
| Treynor Ratio | 0.0507 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VistaGen Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VistaGen Therapeutics Backtested Returns
We consider VistaGen Therapeutics slightly risky. VistaGen Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0119, which indicates the firm had a 0.0119% return per unit of risk over the last 3 months. We have found thirty technical indicators for VistaGen Therapeutics, which you can use to evaluate the volatility of the company. Please validate VistaGen Therapeutics' Risk Adjusted Performance of 0.0311, semi deviation of 3.7, and Coefficient Of Variation of 2755.47 to confirm if the risk estimate we provide is consistent with the expected return of 0.0493%. The entity has a beta of 2.79, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, VistaGen Therapeutics will likely underperform. VistaGen Therapeutics right now has a risk of 4.13%. Please validate VistaGen Therapeutics downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to decide if VistaGen Therapeutics will be following its existing price patterns.
Auto-correlation | -0.9 |
Excellent reverse predictability
VistaGen Therapeutics has excellent reverse predictability. Overlapping area represents the amount of predictability between VistaGen Therapeutics time series from 25th of March 2024 to 9th of April 2024 and 9th of April 2024 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VistaGen Therapeutics price movement. The serial correlation of -0.9 indicates that approximately 90.0% of current VistaGen Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.9 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
VistaGen Therapeutics lagged returns against current returns
Autocorrelation, which is VistaGen Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VistaGen Therapeutics' stock expected returns. We can calculate the autocorrelation of VistaGen Therapeutics returns to help us make a trade decision. For example, suppose you find that VistaGen Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VistaGen Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VistaGen Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VistaGen Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VistaGen Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
VistaGen Therapeutics Lagged Returns
When evaluating VistaGen Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VistaGen Therapeutics stock have on its future price. VistaGen Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VistaGen Therapeutics autocorrelation shows the relationship between VistaGen Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in VistaGen Therapeutics.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VistaGen Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VistaGen Therapeutics' short interest history, or implied volatility extrapolated from VistaGen Therapeutics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VistaGen Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VistaGen Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vistagen Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vistagen Therapeutics Stock:Check out VistaGen Therapeutics Correlation, VistaGen Therapeutics Volatility and VistaGen Therapeutics Alpha and Beta module to complement your research on VistaGen Therapeutics. To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.Note that the VistaGen Therapeutics information on this page should be used as a complementary analysis to other VistaGen Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for VistaGen Stock analysis
When running VistaGen Therapeutics' price analysis, check to measure VistaGen Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VistaGen Therapeutics is operating at the current time. Most of VistaGen Therapeutics' value examination focuses on studying past and present price action to predict the probability of VistaGen Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VistaGen Therapeutics' price. Additionally, you may evaluate how the addition of VistaGen Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
VistaGen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.